Cargando…
117. Trends in Four-class HIV Drug Resistance in Treatment-experienced Patients in the United States
BACKGROUND: Despite the availability of potent antiretroviral therapy, only 56% of people living with HIV in the US were virally suppressed in 2018. Drug resistance can hinder suppression, especially among treatment-experienced patients, in whom the prevalence of 4-class drug resistance (4CR) is unk...
Autores principales: | Curanovic, Dusica, Lai, Johnny, Petropoulos, Christos J, Walworth, Charles M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644880/ http://dx.doi.org/10.1093/ofid/ofab466.117 |
Ejemplares similares
-
691. Results of Repeat HIV-1 DNA Resistance Tests Are Highly Concordant
por: Curanovic, Dusica, et al.
Publicado: (2020) -
HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing
por: Curanovic, Dusica, et al.
Publicado: (2023) -
959. HIV-1 DNA Testing Identifies Drug Resistance in Viremic Patients with Pan-Sensitive Plasma Virus
por: Curanovic, Dusica, et al.
Publicado: (2020) -
2686. High HIV and STI Rates in Patients with MPOX Identified in a Large National Database
por: Alfego, David, et al.
Publicado: (2023) -
Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment
por: Ellis, Ronald J., et al.
Publicado: (2022)